Chow L H, Huh S, Jiang J, Zhong R, Pickering J G
Vascular Biology Group, John P. Robarts Research Institute, London, Ontario, Canada.
Circulation. 1996 Dec 15;94(12):3079-82. doi: 10.1161/01.cir.94.12.3079.
The major threat to the long-term survival of cardiac allograft recipients is the development of diffuse intimal thickening in the allograft coronary arteries through mechanisms that are poorly understood. Although antidonor antibodies have been associated with the development of this condition, a causal relationship has not been established.
To determine whether humoral immune responses are necessary for the development of graft vascular disease, we performed abdominal aortic allografts from normal donor mice into different immunodeficient recipient mice: those lacking all donor-specific immune responses (severe combined immunodeficient [SCID] mice and recombination activating gene-1 [RAG-1]-deficient mice) and those lacking humoral immune responses alone owing to a targeted deletion of the joining region (JH) gene segments for the immunoglobulin heavy chain. At 6 to 9 weeks after transplantation, aortic allografts in normal immunocompetent recipients showed concentric intimal thickening extending the full length of the graft (percent luminal reduction, [%LR], 31.2 +/- 9.1 [mean +/- SD] and 38.5 +/- 3.6 in different donor-recipient strain combinations). In contrast, syngeneic (histocompatible) aortic grafts showed a normal-appearing vessel wall (%LR, 1.6 +/- 0.7). In both SCID and RAG-1-deficient recipients, aortic allografts showed a virtual absence of neointimal formation (%LR, 3.7 +/- 2.1 and 3.8 +/- 1.6 in SCID and RAG-1-deficient recipients, respectively), indicating a critical etiological role for alloimmune responses in this model. Importantly, allografts in JH-deficient mice showed marked intimal thickening (%LR, 35.7 +/- 7.9), with an appearance histologically indistinguishable from that of normal immunocompetent recipients.
Neointimal formation in graft vascular disease is critically dependent on alloimmune responses of the host. Humoral effector mechanisms, however, may not be required.
心脏移植受者长期存活的主要威胁是同种异体移植冠状动脉出现弥漫性内膜增厚,其机制尚不清楚。虽然抗供体抗体与这种情况的发生有关,但尚未确立因果关系。
为了确定体液免疫反应对于移植血管疾病的发生是否必要,我们将正常供体小鼠的腹主动脉移植到不同的免疫缺陷受体小鼠体内:缺乏所有供体特异性免疫反应的小鼠(严重联合免疫缺陷[SCID]小鼠和重组激活基因-1[RAG-1]缺陷小鼠),以及因免疫球蛋白重链连接区(JH)基因片段靶向缺失而仅缺乏体液免疫反应的小鼠。移植后6至9周,正常免疫活性受体中的主动脉移植显示同心内膜增厚,延伸至移植血管的全长(不同供体-受体品系组合中管腔减少百分比,[%LR],分别为31.2±9.1[平均值±标准差]和38.5±3.6)。相比之下,同基因(组织相容性)主动脉移植显示血管壁外观正常(%LR,1.6±0.7)。在SCID和RAG-1缺陷受体中,主动脉移植几乎没有新内膜形成(SCID和RAG-1缺陷受体中%LR分别为3.7±2.1和3.8±1.6),表明在该模型中同种异体免疫反应起关键病因作用。重要的是,JH缺陷小鼠中的移植显示出明显的内膜增厚(%LR,35.7±7.9),其组织学外观与正常免疫活性受体的无异。
移植血管疾病中的新内膜形成严重依赖于宿主的同种异体免疫反应。然而,可能不需要体液效应机制。